A significant quality control failure has been identified in Cardinal Health Webcol Large Alcohol Prep Pads supplied within custom convenience kits. These products, which failed sterility testing, represent an unacceptable infection risk when used in clinical procedures requiring aseptic technique.
The FDA’s issuance of an early alert reflects the severity of this defect and the potential for patient harm across multiple healthcare facilities. Non-sterile prep pads used in clinical settings can introduce pathogens at procedure sites, leading to healthcare-associated infections with serious complications. This quality failure underscores the critical importance of rigorous sterility testing protocols before distribution.
The agency is actively investigating the scope and severity of affected units. Healthcare facilities must immediately verify their inventory, quarantine suspicious batches, and implement interim safeguards. This incident highlights the essential role of robust medical device oversight in protecting patient safety. Read the full article on GMJ Newsroom.
Was this article helpful?
